Trial intelligence / Profile preview

Kore Fiber vs Autograft in Posterolateral Lumbar Fusion

NCT07868510Not yet recruiting

Sponsor
Kolosis BIO
Start
Nov 2026
Primary completion
Nov 2028
Countries
1
01

Overview

Randomised trial (2 arms), sponsored by Kolosis BIO. Primary endpoint: Rate of successful fusion at 1 year. Planned start Nov 2026; status: not yet recruiting.

Beyond the preview

Go deeper on NCT07868510.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07868510.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call